Valsartan Sacubitril Introduction
Valsartan Sacubitril is an experimental drug developed for the treatment of patients with heart failure with reduced ejection fraction (HFrEF). The data demonstrate that LCZ696 surpasses the clinical standard drug enalapril in efficacy and safety, including a significant reduction in the risk of cardiovascular death or hospitalization for heart failure.
Valsartan Sacubitril Specification
| Appearance |
white powder |
| Molecular Weight |
957.99 |
| Content |
99.0% |
| Storage Condition |
Room temperature |
| Packaging |
5mg, 10mg, 50mg |
Valsartan Sacubitril Applications
Valsartan Sacubitril is an experimental drug developed for the treatment of patients with heart failure with reduced ejection fraction (HFrEF).